Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People who have been diagnosed with invasive breast cancer (confirmed through tissue testing) that can be surgically removed and has not spread to other parts of the body (Stage I–III)
- People who have not yet received any treatment for breast cancer and are planning to have surgery and other treatments
- People who are reasonably active and able to carry out daily activities (as measured by a standard medical scale rated 0–2, where 0 means fully active and 2 means limited in physical activity but able to care for oneself)
- People whose blood, liver, and kidney test results fall within acceptable ranges, including healthy red blood cell, white blood cell, and platelet levels, as well as liver enzyme and kidney function values within specified limits
- People who have given written, voluntary consent to participate in the trial
Who may not be able to join:
- People who have had another serious cancer in the past 5 years that is still active or requires ongoing treatment (certain skin cancers, early-stage breast or cervical cancers that have been fully treated may not apply — confirm with trial site)
- People with a known history of a neurological or psychiatric condition, such as epilepsy or dementia, or a history of substance or drug misuse
- People with a known allergy to any components used in the trial's treatment approach, a history of immune system deficiency, or a history of organ transplantation
- People with other serious ongoing health conditions that could affect their safety or ability to complete the trial, such as serious infections, liver disease, heart disease, kidney disease, lung disease, or poorly controlled diabetes or abnormal cholesterol levels
- People who are pregnant or breastfeeding
- People who the trial doctor determines are not suitable for the study for other reasons
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Fei Ma, Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phone: 86-10-87788060
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
3 years disease free survival(DFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.